Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review

Taehwan Park; Scott K. Griggs; Dong Churl Suh

doi:10.1007/s40259-015-0135-4

Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review

Taehwan Park
, Scott K. Griggs
, Dong Churl Suh

Pharmaceutical and Administrative Sciences Department

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	259-274
Number of pages	16
Journal	BioDrugs
Volume	29
Issue number	4
DOIs	https://doi.org/10.1007/s40259-015-0135-4
State	Published - Aug 13 2015

ASJC Scopus Subject Areas

Biotechnology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/s40259-015-0135-4

Cite this

@article{61c69ba481724e00b7453ae859b89ea0,

title = "Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review",

author = "Taehwan Park and Griggs, \{Scott K.\} and Suh, \{Dong Churl\}",

note = "Publisher Copyright: {\textcopyright} 2015 Springer International Publishing Switzerland.",

year = "2015",

month = aug,

day = "13",

doi = "10.1007/s40259-015-0135-4",

language = "English",

volume = "29",

pages = "259--274",

journal = "BioDrugs",

issn = "1173-8804",

number = "4",

}

TY - JOUR

T1 - Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases

T2 - A Systematic Review

AU - Park, Taehwan

AU - Griggs, Scott K.

AU - Suh, Dong Churl

PY - 2015/8/13

Y1 - 2015/8/13

UR - https://www.scopus.com/pages/publications/84941413236

UR - https://www.scopus.com/pages/publications/84941413236#tab=citedBy

U2 - 10.1007/s40259-015-0135-4

DO - 10.1007/s40259-015-0135-4

M3 - Review article

C2 - 26263903

AN - SCOPUS:84941413236

SN - 1173-8804

VL - 29

SP - 259

EP - 274

JO - BioDrugs

JF - BioDrugs

IS - 4

ER -

Cost Effectiveness of Monoclonal Antibody Therapy for Rare Diseases: A Systematic Review

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this